CoolSculpting, launched in the US in 2010, is a technology-based system which basically freezes fat cells away. As discussed above, when we gain and lose weight, our fat cells basically grow and shrink, but our proportions pretty much stay the same. CoolSculpting is revolutionary in that it lets you target your stubborn fat with “spot treatment.” That means the fat comes off where you want it too. And for the first time, safe and effective spot reduction of fatty bulges can be performed noninvasively, and with no downtime.
No AXA PPP Group company will be liable for any loss, damage or personal injury whatsoever suffered or sustained in connection with the PureGym membership and/or use of the PureGym club(s) except for any liability which cannot be excluded by law (including fraud or for the death or personal injury caused by that AXA PPP Group company’s negligence).
Meanwhile, all Gold and Diamond Marco Polo Club members regardless of their country of residence will now be eligible for one-day access passes to any Pure Fitness centre, or enrolment in any class at a Pure Yoga studio in Hong Kong. These must coincide with either the day of arrival or the day immediately after, with a total of 12 one-day/class access passes permitted in a single calendar year.
CoolSculpting works by taking advantage of the fact that fat cells are more sensitive to cold than the other cells around them. This basic scientific fact was first discovered in 1970 by doctors observing children who sucked on popsicles for hours, and ended up having first soreness, and later dimples, caused by loss of fat cells! Fast forward about 20 years, and Harvard scientists revisited this fact, and realized that they could turn this science into a system for aesthetic sculpting of fatty bulges. The key was to find the ‘sweet spot’ of time and temperature, which would kill some fat cells but not damage surrounding structures such as skin. They called the public company that makes the systems Zeltiq. The proof of the success of this concept and treatment: Zeltiq was bought out by Allergan in 2016 for whopping 2.5 billion! This was the largest sale of a single medical device company in history.
1 July 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.